A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Nature Medicine2005Vol. 11(5), pp. 551–555
Citations Over TimeTop 1% of 2005 papers
Mark H. Tuszynski, Leon J. Thal, Mary Pay, David P. Salmon, Hoi Sang U, Roy A.E. Bakay, Piyush M. Patel, Armin Blesch, H. Lee Vahlsing, Gilbert Ho, Gang Tong, Steven G. Potkin, James Fallon, Lawrence A. Hansen, Elliott J. Mufson, Jeffrey H. Kordower, Christine M. Gall, J. M. Conner
Related Papers
- → Acute and long-term exposure to chlorpyrifos induces cell death of basal forebrain cholinergic neurons through AChE variants alteration(2015)24 cited
- → Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats(1988)208 cited
- → Cell Biology of the Forebrain Cholinergic Neurons: Effects of NGF, Triiodothyronine and Gangliosides(1986)1 cited
- Cholinergic basis of nerve growth factor in the treatment of Alzheimers disease(2004)
- → Cholinergic Phenotype of Septal Cell Lines(1992)